Summaiy The presence of the BCL-2 protein was studied in nine non-Hodgkin's lymphomas with testicular localisation. A consistent presence of the BCL-2 protein was found. The chromosomal translocation (14;18) was seen neither by cytogenetic analysis (n = 4) nor by polymerase chain reaction amplification and Southern blotting (n = 9). Therefore, this translocation is not responsible for the presence of the BCL-2 protein in non-Hodgkin's lymphomas with testicular localisation. We suggest that the presence of the BCL-2 protein in these lymphomas is related to the differentiation stage of the B-lymphocytes or may play a role in the pathogenesis of these lymphomas. The consistent finding of the BCL-2 protein in lymphomas with testicular localisation may support the clinical observation that these lymphomas are a separate entity.
extremely rare. They may occur as a primary manifestation or in the context of dissemination of nodal NHL (secondary testicular NHL) (Doll and Weis, 1986; Hamilton and Horwich, 1988; Martenson et al., 1988; Lukes and Collins, 1992) . Thus far, there are no criteria to discriminate between these two. These NHLs of the testis are usually diffuse large-cell NHLs according to the Working Formulation for lymphomas (Doll and Weis, 1986; Hamilton and Horwich. 1988 ; Martenson et al., 1988; Lukes and Collins, 1992) . The prognosis of NHL with testicular localisation is poor; most patients die of disseminated NHL within 2 years. In addition, they show a specific pattern of metastases, e.g. extranodal sites such as the upper airways, central nervous system and bones are especially involved (Doll and Weis, 1986; Hamilton and Horwich. 1988) .
Translocation between chromosomes 14 and 18 [t(14q32;18q21) ] is found in 60-85% of follicular NHLs and 20-30% of diffuse large-cell NHLs (Aisenberg et al., 1988; Rowley, 1988; Griesser and Lennert, 1990; Pezzella et al., 1990a; Lambrechts et al.. 1992; Limpens et al., 1992) . Because of the t(14;18) the B-cell lymphoma 2 (BCL-2) gene located on the long arm of chromosome 18 is juuxtaposed to the joining (JH) region of the immunoglobulin heavy-chain (IgH) gene located on the long arm of chromosome 14 (Tsujimoto et al., 1984; Bakhshi et al., 1985; Cleary & Sklar, 1985; Korsmeyer, 1992) . This results in an enhanced expression of the BCL-2 gene, which subsequently results in a disturbed programmed cell death (PCD). i.e. a prolonged cell survival (Vaux et al., 1988; Hockenbery et al., 1990; Nunez et al., 1990; Henderson et al., 1991; Garcia et al., 1992) .
In follicular NHL, diffuse large-cell NHL and NHL of the gastrointestinal tract, the BCL-2 protein is found using immunohistochemistry (Ngan et al., 1988; Pezzella et al., 1990b; Zutter et al., 1991; Gaulard et al., 1992; Kondo et al., 1992; LeBurn et al., 1992 Nunez et al. 1991; Pettersson et al. 1992 ). In nearly all follicular NHLs, independent of the presence of the t(14;18), the BCL-2 protein is present (Ngan et al., 1988 (Ngan et al., 1988; Pezzella et al., 1990b; Zutter et al., 1991; Kondo et al., 1992) . NHLs of the gastrointestinal tract, neoplasms in which t(14;18) occurs infrequently, exhibit the BCL-2 protein in about 50% of cases (Kondo et al., 1992; LeBurn et al., 1992) . Thus, the BCL-2 protein is found in normal lymphoid cells and in many different histological subtypes of NHL independent of the presence of the t(14;18).
In the context that NHLs with testicular localisation show a separate clinical identity among NHL, we investigated the presence of the t(14;18) by combining cytogenetic analysis (n = 4), polymerase chain reaction (PCR) and Southern blotting (n = 9). The presence of the BCL-2 protein was studied using immunohistochemistry on frozen tissue sections (n = 9).
Material and methods

Samples
Tumour samples were collected in The Netherlands from nine patients with NHL localised in the testis. The tumours were classified according to the Working Formulation for lymphomas by a panel of pathologists (National Cancer Institute sponsored study of classification of non-Hodgcin's lymphomas, 1982). Staging was according to the Ann Arbor classification (Carbone et al., 1971) . Representative frozen tissue sections were used for immunohistochemical and immunofluorescence analysis (Lambrechts et al., 1992) .
Immunohistochemistrv
Frozen tissue sections were fixed in acetone (100%) for 10 min. Endogenous peroxidase activity was blocked using 0.3% hydrogen peroxide in phosphate-buffered saline (PBS), containing 0.2% bovine serum albumin (BSA) . Expression of the BCL-2 protein was studied using a mouse monoclonal antibody, BCL-2 lOOa (kindly provided by Drs F Pezzella and DY Mason; Pezzella et al., 1990b) . Visualisation was performed using an indirect peroxidase assay with a streptavdin-biotin-conjugated goat anti-mouse immunoglobulin antibody as a second step. Hyperplastic lymph nodes were used as positive controls. 
Cytogenetic analysis
Cytogenetic analysis was performed on metaphase spread chromosome of four cases according to standard procedures (Gibas et al., 1984) . The chromosomes were identified with G banding (GTG banding) and described according to ISCN 1991 (Mittelman, 1991 .
DNA extraction and polymerase chain reaction (PCR) analjysis High molecular weight DNA was isolated from frozen tissue sections of all NHLs with testicular localisation. DNA was digested with HindIII and analysed for t(14;18) and immunoglobulin heavy-chain rearrangement (IgH) using Southern blotting and probing with BCL-2 (Bakhshi et al., 1985) and the joining region of IgH allele (JH) (Takahasi et al., 1980) . In addition, PCR was used to detect small amounts of t(14;18)-positive cells. PCR primers were designed for the major breakpoint region (mbr: 5'-GGTGGTTTGACCTTTAGA-3') of the BCL-2 gene and the consensus region of the JH genes (5'-TGAGGAGACG-GTGACC-3') (Lambrechts et al., 1992) . As a control to DNA quality the interleukin-3 gene of the DNA was amplified in 25 cycles, as described previously (Lambrechts et al., 1992) . For the detection of t(14;18) a total of 0.5-1.Oig of DNA in a reaction volume of 25-501lI was subjected to 30 cycles of PCR amplification using an automated PerkinElmer/Cetus DNA thermal cycler (Gouda, The Netherlands).
In each experiment positive and negative controls were included. As positive controls different dilutions of DNA from a mbr t(14;18)-positive cell line (SU-DHL-6) or DNA from a mcr t(14;18)-positive lymph node biopsy was used. Amplified samples were analysed as described using the BCL-2 and JH probes (Lambrechts et al., 1992 ). 
Results
The age of the patient. the localisation and the stage of disease at diagnosis, response to treatment, the localisation of metastasis at relapse and the histological subtype of the non-Hodgkin's lymphoma localised in the testis are summarised in Table I del(I 1Xq22q23), add(18Xq21) (Doll and Weis, 1986; Hamilton and Horwich, 1988 Table   I ).
BCL-2 and besdw non4iod9bn's yphomas AC Lanbrechts et al 76 (Aisenberg et al., 1988 : Rowley, 1988 Gnresser and Lennert, 1990; Pezzella el al.. 1990a; Lambrechts et al.. 1992; Limpens et al., 1992 (Kondo et al., 1992; LeBurn et al., 1992) . While the BCL-2 protein was present in normal lymphoid cells. no BCL-2 protein was reported in normal testis : Nunez et al., 1991 Pettersson et al.. 1992) . Our data show the presence of the BCL-2 protein in all of the NHLs with testicular localisation studied. Thus. in all cases of NHL with testicular localisation we studied, the BCL-2 protein is consistently present without a t(14;18). In spite of the relatively small number of cases, this finding supports the clinical observation that NHL with testicular localisation may represent a separate subgroup of large-cell lymphomas which is distinct from progressed follicular lymphoma. The presence of the BCL-2 protein may represent a differentiation stage of the B lymphocyte or a functional subpopulation of B lymphocytes.
